Immuneering (IMRX) Q4 2024 Earnings

13NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.55
-0.37
-0.18
0

Details

Expected EPS
-0.551857
Actual EPS
-0.49
Surprise EPS
0.06
Surprise Percent
+11.21%

Description

Immuneering (IMRX) has reported earnings of -0.49 per share for Q4 2024.

0 Comments

Share your thoughts